MA53291A - Particules contenant des agents colorants et procédés pour les utiliser - Google Patents

Particules contenant des agents colorants et procédés pour les utiliser

Info

Publication number
MA53291A
MA53291A MA053291A MA53291A MA53291A MA 53291 A MA53291 A MA 53291A MA 053291 A MA053291 A MA 053291A MA 53291 A MA53291 A MA 53291A MA 53291 A MA53291 A MA 53291A
Authority
MA
Morocco
Prior art keywords
methods
coloring agents
particles containing
containing coloring
particles
Prior art date
Application number
MA053291A
Other languages
English (en)
Inventor
Brennal Pierre
Vandan K Shah
Original Assignee
Ephemeral Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ephemeral Solutions Inc filed Critical Ephemeral Solutions Inc
Publication of MA53291A publication Critical patent/MA53291A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/85—Polyesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/025—Semi-permanent tattoos, stencils, e.g. "permanent make-up"
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42—Colour properties
    • A61K2800/43—Pigments; Dyes
    • A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/654—The particulate/core comprising macromolecular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
MA053291A 2018-08-10 2019-08-09 Particules contenant des agents colorants et procédés pour les utiliser MA53291A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862717584P 2018-08-10 2018-08-10

Publications (1)

Publication Number Publication Date
MA53291A true MA53291A (fr) 2022-05-11

Family

ID=69415687

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053291A MA53291A (fr) 2018-08-10 2019-08-09 Particules contenant des agents colorants et procédés pour les utiliser

Country Status (11)

Country Link
US (2) US20210154107A1 (fr)
EP (1) EP3833318A4 (fr)
JP (1) JP2021534242A (fr)
CN (1) CN113194907A (fr)
AU (1) AU2019320082B2 (fr)
BR (1) BR112021007900A2 (fr)
CA (1) CA3108431A1 (fr)
IL (1) IL280655A (fr)
MA (1) MA53291A (fr)
SG (1) SG11202101047RA (fr)
WO (1) WO2020033903A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12403293B2 (en) * 2020-11-10 2025-09-02 Jason Candreva Medical device for applying semi-permanent tattoo ink
CA3208608A1 (fr) * 2021-02-12 2022-08-18 Ephemeral Solutions, Inc. Particules contenant des agents colorants et procedes pour les utiliser
CN113786351A (zh) * 2021-09-30 2021-12-14 江苏省中国科学院植物研究所 氯法齐明作为染发剂的新用途
CN114318604B (zh) * 2021-12-15 2022-11-18 苏州大学 一种光致变色混纺棉纱及其制备方法和应用
WO2023178213A2 (fr) * 2022-03-15 2023-09-21 Ephemeral Solutions, Inc. Méthodes de marquage d'un emplacement cible pour une procédure médicale
CN115420692B (zh) * 2022-07-18 2025-07-29 温州医科大学 一种具有类过氧化物酶催化活性的Fe3S4/CDs纳米材料及应用
US12115236B1 (en) * 2022-11-07 2024-10-15 Michelle Norvell Tattoo ink formulation and method
WO2024256696A1 (fr) * 2023-06-15 2024-12-19 Nanexa Ab Nouvelles compositions pharmaceutiques injectables à effet retard
AU2024331964A1 (en) * 2023-08-31 2026-03-12 Fluidx Medical Technology, Inc. Polyelectrolyte hydrogel formulations and methods for making and using the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE69232555T2 (de) * 1991-02-01 2002-10-31 Massachusetts Institute Of Technology, Cambridge Biologisch abbaubare Polymermischungen zur Arzneistoffabgabe
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
JPH11507038A (ja) * 1995-06-07 1999-06-22 ユニヴァースティ オブ サザーン カリフォルニア ５−リポキシゲナーゼ阻害剤を用いる、術後癒着形成を低減又は阻止する方法
US6013122A (en) * 1998-08-18 2000-01-11 Option Technologies, Inc. Tattoo inks
WO2002039961A1 (fr) * 2000-11-15 2002-05-23 L'oreal Composition cosmetique comprenant une dispersion de particules de polymere et une dispersion de pigments
US20040253293A1 (en) * 2003-06-16 2004-12-16 Afshin Shafiee Rate controlled release of a pharmaceutical agent in a biodegradable device
AU2005227192A1 (en) * 2004-03-11 2005-10-06 Kythera Biopharmaceuticals, Inc. Compositions and methods for preventing and treating skin and hair conditions
US20090217840A1 (en) * 2005-08-19 2009-09-03 Freedom-2, Inc. Cellular or organelle-entrapped nanoparticles
US20090311295A1 (en) * 2006-05-12 2009-12-17 Edith Mathiowitz Particles with high uniform loading of nanoparticles and methods of preparation thereof
US20100015195A1 (en) * 2006-10-05 2010-01-21 Rajesh Jain Injectable depot compositions and it's process of preparation
US8828419B2 (en) * 2006-10-06 2014-09-09 Cordis Corporation Bioabsorbable device having encapsulated additives for accelerating degradation
US20100069726A1 (en) * 2008-06-04 2010-03-18 Seventh Sense Biosystems, Inc. Compositions and methods for rapid one-step diagnosis
ES2770273T3 (es) * 2008-06-27 2020-07-01 Tepha Inc Administración inyectable de micropartículas y composiciones para ello
US20120042882A1 (en) * 2010-08-23 2012-02-23 Massachusetts Institute Of Technology Particles with charged surface domains
WO2012071013A1 (fr) * 2010-11-24 2012-05-31 Nanyang Technological University Procédé pour l'encapsulation de particules
US9149426B2 (en) * 2012-02-15 2015-10-06 University Of Tennessee Research Foundation Nanoparticle composition and methods to make and use the same
US9072678B2 (en) * 2013-03-14 2015-07-07 Pathak Holdings Llc Methods for local drug delivery by microinjection
BR112016015985A2 (pt) * 2014-01-10 2017-09-19 Chamber Works Llc Composição e métodos de preparação da composição e de fornecimento de substância personalizadora à pele de indivíduos
KR102329359B1 (ko) * 2014-03-04 2021-11-23 타그라 바이오테크놀로지스 리미티드 색소 함유 미세캡슐
WO2016161944A1 (fr) * 2015-04-07 2016-10-13 Sichuan Revotek Co., Ltd. Compositions pour impression tridimensionnelle à base de cellules
WO2017177184A1 (fr) * 2016-04-08 2017-10-12 Ultra Ink, Inc. Encre pour tatouage éliminable et son procédé de production
US10179179B2 (en) * 2016-10-28 2019-01-15 Nano And Advanced Materials Institute Limited Magnetic nanoparticles for disease diagnostics

Also Published As

Publication number Publication date
WO2020033903A1 (fr) 2020-02-13
CA3108431A1 (fr) 2020-02-13
CN113194907A (zh) 2021-07-30
US20210154107A1 (en) 2021-05-27
SG11202101047RA (en) 2021-02-25
BR112021007900A2 (pt) 2021-08-03
JP2021534242A (ja) 2021-12-09
AU2019320082B2 (en) 2025-02-06
US20250017828A1 (en) 2025-01-16
EP3833318A4 (fr) 2022-05-11
EP3833318A1 (fr) 2021-06-16
AU2019320082A1 (en) 2021-06-10
IL280655A (en) 2021-03-25

Similar Documents

Publication Publication Date Title
MA53291A (fr) Particules contenant des agents colorants et procédés pour les utiliser
FR23C1015I1 (fr) Procédés de sélection d'une lignée de lymphocytes t et donneur de lignée de lymphocytes t pour thérapie cellulaire adoptive
EP3874030A4 (fr) Compositions et procédés pour l'ingénierie des lymphocytes t
MA50858A (fr) Procédés, compositions et composants pour l'édition crispr-cas9 de tgfbr2 dans des cellules t pour l'immunothérapie
EP3697420A4 (fr) Procédés d'utilisation d'inhibiteurs d'ehmt2 dans des immunothérapies
EP3160661C0 (fr) Système et procédés pour l'anti-encrassement biologique
EP3451837A4 (fr) Protéines insecticides et procédés pour les utiliser
EP3414311A4 (fr) Compositions et procédés destinés à être utilisés pour décontaminer des surfaces
MA50636A (fr) Compositions et procédés pour inhiber l'activité d'arginase
EP3635100A4 (fr) Compositions et procédés pour exprimer l'otoferline
EP3443013A4 (fr) Procédés d'utilisation de l'expression de pd-l1 dans des décisions de traitement pour la thérapie anticancéreuse
EP3387131A4 (fr) Agents polynucléotides ciblant le ligand 1 de la mort cellulaire programmée 1 (pd-l1) et leurs méthodes d'utilisation
EP3402483A4 (fr) Procédés et compositions pour l'activation de lymphocytes t gamma-delta
EP3356393A4 (fr) Compositions et procédés pour le positionnement adjacent de domaines extracellulaires de type i et de type ii en tant que protéines chimériques hétérologues
EP3408646A4 (fr) Procédés et appareil de caractérisation d'un récipient d'échantillon et d'un échantillon
EP3448981A4 (fr) Compositions et procédés pour réaliser des séparations magnétiflottantes
EP3402494A4 (fr) Protéines chimériques et procédés d'immunothérapie
EP3350201A4 (fr) Phytases modifiées et procédés pour les utiliser
EP3331960A4 (fr) Agents d'inversion non ioniques pour latex eau-dans-huile et procédés d'utilisation
EP3364968A4 (fr) Composés d'oxazolidinone et procédés pour les utiliser comme agents antibactériens
EP3393470A4 (fr) Analogues de fenfluramine résistant au métabolisme et procédés pour les utiliser
EP3377069A4 (fr) Composition de phéromone pour stimuler la reproduction chez des femelles suidés et procédés d'utilisation
EP3488018A4 (fr) Procédés et compositions pour l'identification de protéines
EP3307284A4 (fr) Compositions et procédés pour l'enrichissement de cellules
EP3426349A4 (fr) Procédés et compositions pour inhiber l'expression de pmp22